Immunic's three largest insider shareholders as of August 29, 2026 are Daniel Vitt (President And Ceo, 390.88K shares), Andreas Muehler (Chief Medical Officer, 297.99K shares), Glenn Whaley (Chief Financial Officer, 95.51K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Andreas Muehler | Chief Medical Officer | 297,986 | 0 | 297,986 | 70.3% | 16 May, 2022 |
| 2 | Glenn Whaley | Chief Financial Officer | 95,510 | 0 | 95,510 | 22.5% | 04 Jun, 2025 |
| 3 | Daniel Vitt | Ceo And Director | 29,000 | 0 | 29,000 | 6.8% | 20 Jun, 2025 |
| 4 | Richard Alan Rudick | Director | 576 | 0 | 576 | 0.1% | 04 Jun, 2025 |
| 5 | Joerg Neermann | Director | 500 | 0 | 500 | 0.1% | 05 Jun, 2025 |
| 6 | Duane Nash | Executive Chairman | 90 | 0 | 90 | 0.0% | 16 Jun, 2025 |
| 7 | Jason Tardio | President And Coo | 31 | 0 | 31 | 0.0% | 20 Jun, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 06 Aug, 2026 | Elena Ridloff | Director | Acquired A | 50,740 | $0.00 | $0 | 50,740 | Direct |
| 05 Jul, 2026 | Barclay A Phillips | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Simona Skerjanec | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Richard Alan Rudick | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Jon Congleton | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 05 Jul, 2026 | Joerg Neermann | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Barclay A Phillips | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Michael W Bonney | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 29 Jun, 2026 | Joerg Neermann | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Richard Alan Rudick | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Jason Tardio | President And Coo | Acquired A | 253,000 | $0.00 | $0 | 253,000 | Direct |
| 29 Jun, 2026 | Glenn Whaley | Chief Financial Officer | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 29 Jun, 2026 | Simona Skerjanec | Director | Acquired A | 25,370 | $0.00 | $0 | 25,370 | Direct |
| 29 Jun, 2026 | Daniel Vitt | Director | Acquired A | 445,000 | $0.00 | $0 | 445,000 | Direct |
| 29 Jun, 2026 | Jon Congleton | Director | Acquired A | 50,740 | $0.00 | $0 | 50,740 | Direct |
| 22 May, 2026 | Erik Lundgren | Chief Executive Officer | Acquired A | 1,000,000 | $0.00 | $0 | 1,000,000 | Direct |
| 24 Apr, 2026 | Michael A. Panzara | Chief Medical Officer | Acquired A | 300,000 | $0.00 | $0 | 750 | Direct |
| 16 Jul, 2025 | Andreas Muehler | Chief Medical Officer | Acquired A | 330,000 | $0.00 | $0 | 330,000 | Direct |
| 16 Jul, 2025 | Andreas Muehler | Chief Medical Officer | Acquired A | 330,000 | $0.00 | $0 | 330,000 | Direct |
| 16 Jul, 2025 | Daniel Vitt | Ceo And Director | Acquired A | 860,000 | $0.00 | $0 | 860,000 | Direct |